The Ratings Game: As Illumina stock bounces off a 10-year low, analysts see no quick fix

DNA-sequencing company juggles leadership transition, questions about a new product launch, and unwinding of a troubled acquisition 

Previous post Market Extra: Gold futures eye highest finish in a week after U.S. inflation data
Next post The Moneyist: Is it OK for my new boyfriend to ask me to split the bill? ‘I don’t want him to get used to me paying for my own meals.’